Andrea S Leung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea S Leung has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Baoli Zhu
Beijing Key Laboratory of Antimicrobial-Resistant Pathogen Microbiology and AI-Empowered Containment, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
1 shared publication - David C. Alexander
Cadham Provincial Laboratory, Winnipeg, MB, Canada
1 shared publication - George Fu Gao
Beijing Key Laboratory of Antimicrobial-Resistant Pathogen Microbiology and AI-Empowered Containment, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
1 shared publication - Jun Liu
Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
1 shared publication - Vanessa Tran
Tropical Disease Unit, The University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada
1 shared publication - Xuping Yu
College of Animal Sciences, Zhejiang University, Hangzhou 310029, China
1 shared publication
Latest Publications
- Open Access
- 15 September 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 413
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy
Bacille Calmette-Guérin (BCG) is an attenuated strain ofMycobacterium boviscurrently used as a vaccine against tuberculosis. Global distribution and propagation of BCG has contributed to thein vitroevolution of the vaccine strain and is thought to partially account for the different outcomes of BCG vaccine trials. Previous efforts by several molecular techniques effectively identified large sequence polymorphisms among BCG daughter strains, but lacked the resolution to identify smaller changes. In this study, we have used a NimbleGen tiling array for whole genome comparison of 13 BCG strains. Using this approach, in tandem with DNA resequencing, we have identified six novel large sequence polymorphisms including four deletions and two duplications in specific BCG strains. Moreover, we have uncovered various polymorphisms in thephoP-phoRlocus. Importantly, these polymorphisms affect genes encoding established virulence factors including cell wall complex lipids, ESX secretion systems, and the PhoP-PhoR two-component system. Our study demonstrates that major virulence factors are different among BCG strains, which provide molecular mechanisms for important vaccine phenotypes including adverse effect profile, tuberculin reactivity and protective efficacy. These findings have important implications for the development of a new generation of vaccines.
- 15 September 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 413
Open AccessNovel genome polymorphisms in BCG vaccine strains and impact on efficacy
Bacille Calmette-Guérin (BCG) is an attenuated strain ofMycobacterium boviscurrently used as a vaccine against tuberculosis. Global distribution and propagation of BCG has contributed to thein vitroevolution of the vaccine strain and is thought to partially account for the different outcomes of BCG vaccine trials. Previous efforts by several molecular techniques effectively identified large sequence polymorphisms among BCG daughter strains, but lacked the resolution to identify smaller changes. In this study, we have used a NimbleGen tiling array for whole genome comparison of 13 BCG strains. Using this approach, in tandem with DNA resequencing, we have identified six novel large sequence polymorphisms including four deletions and two duplications in specific BCG strains. Moreover, we have uncovered various polymorphisms in thephoP-phoRlocus. Importantly, these polymorphisms affect genes encoding established virulence factors including cell wall complex lipids, ESX secretion systems, and the PhoP-PhoR two-component system. Our study demonstrates that major virulence factors are different among BCG strains, which provide molecular mechanisms for important vaccine phenotypes including adverse effect profile, tuberculin reactivity and protective efficacy. These findings have important implications for the development of a new generation of vaccines.